Medical Condition

alcoholic cirrhosis

Total Trials

4

Recruiting Now

4

Trial Phases

Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for alcoholic cirrhosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Trial Phases

Phase 2

Phase 3

Top Sponsors

Pharmicell Co., Ltd. 2 trials

Copenhagen University Hospital, Hvidovre 1 trial

Indiana University 1 trial

NCT05093881

Recruiting

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

Optimized Remission in Alcohol-related Liver Cirrhosis

Copenhagen University Hospital...

View Trial →

NCT04250259 Phase 2

Recruiting

SAMe Trial for Patients With Alcoholic Cirrhosis

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology